advanced search

Welcome: Guest

log in

United Kingdom Wound Care Management Investment Opportunities, Analysis and Forecasts to 2015

Publication Date June 2009
Publisher Global Markets Direct
Product Type Report
Pages 118
ISBN Number not applicable
Product Code GMD07500
Buy this product or for assistance call +44 20 7060 7474

Summary

United Kingdom Wound Care Management Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to the UK wound care management market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the wound care management market in the UK

Scope

  • The report provides wound care management information broken down into detailed categories and segments in United Kingdom.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the wound care management market in United Kingdom.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Content

  • 1 Table of Contents
    • 1.1 1.2 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of Markets Covered in This Report
    • 3.1 Wound Care Management
    • 3.2 Advanced Wound Management
      • 3.2.1 Alginates
      • 3.2.2 Collagens
      • 3.2.3 Foams
      • 3.2.4 Hydrocolloids
      • 3.2.5 Hydrofibres
      • 3.2.6 Hydrogels
      • 3.2.7 Negative Pressure Wound Therapy (NPWT)
      • 3.2.8 Semi-Permeable Films
    • 3.3 Compression Therapy
    • 3.4 Ostomy
    • 3.5 Traditional Wound Management
    • 3.6 Wound Closure Devices
      • 3.6.1 Skin Closure Devices
      • 3.6.2 Tissue Sealants
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Expenditure
    • 4.2 Healthcare Infrastructure
    • 4.3 Healthcare Policy
    • 4.4 United Kingdom Healthcare Trade Statistics
  • 5 Regulation System
    • 5.1 Medical Equipment Approval Process
      • 5.1.1 Classification of Medical Devices
      • 5.1.2 Conformity Assessment Process
        • 5.1.2.1 Class I devices
        • 5.1.2.2 Class IIa devices
        • 5.1.2.3 Class IIb devices
        • 5.1.2.4 Class III devices
    • 5.2 Medical Device approval fee
    • 5.3 Post Market Surveillance (PMS)
  • 6 Pricing and Reimbursement
    • 6.1 Market Pricing
    • 6.2 Government Policies for Reimbursement
  • 7 Distribution Structure
  • 8 Wound Care Management In United Kingdom
    • 8.1 Wound Care Management Cross Country Comparison, Revenue ($ mn), 2000-2015
    • 8.2 Wound Care Management, United Kingdom, Overall Revenue ($ mn), 2000-2015
    • 8.3 Wound Care Management, United Kingdom, Category Volume (Units), 2000-2015
    • 8.4 Wound Care Management, United Kingdom, Company Share (2006-2007)
  • 9 Advanced Wound Management In United Kingdom
    • 9.1 Advanced Wound Management Overall Revenue (2000-2015)
    • 9.2 Advanced Wound Management Overall Volume (2000-2015)
    • 9.3 Advanced Wound Management Average Price (2000-2015)
    • 9.4 Advanced Wound Management Distribution Share (2007-2008)
    • 9.5 Advanced Wound Management, United Kingdom, Company Share (2006-2007)
  • 10 Compression Therapy In United Kingdom
    • 10.1 Compression Therapy Overall Revenue (2000-2015)
    • 10.2 Compression Therapy Overall Volume (2000-2015)
    • 10.3 Compression Therapy Average Price (2000-2015)
    • 10.4 Compression Therapy Distribution Share (2007-2008)
    • 10.5 Compression Therapy, United Kingdom, Company Share (2006-2007)
  • 11 Ostomy In United Kingdom
    • 11.1 Ostomy Overall Revenue (2000-2015)
    • 11.2 Ostomy Overall Volume (2000-2015)
    • 11.3 Ostomy Average Price (2000-2015)
    • 11.4 Ostomy Distribution Share (2007-2008)
    • 11.5 Ostomy, United Kingdom, Company Share (2006-2007)
  • 12 Traditional Wound Management In United Kingdom
    • 12.1 Traditional Wound Management Overall Revenue (2000-2015)
    • 12.2 Traditional Wound Management Overall Volume (2000-2015)
    • 12.3 Traditional Wound Management Average Price (2000-2015)
    • 12.4 Traditional Wound Management Distribution Share (2007-2008)
    • 12.5 Traditional Wound Management, United Kingdom, Company Share (2006-2007)
  • 13 Wound Closure Devices In United Kingdom
    • 13.1 Wound Closure Devices Overall Revenue (2000-2015)
    • 13.2 Wound Closure Devices Overall Volume (2000-2015)
    • 13.3 Wound Closure Devices Average Price (2000-2015)
    • 13.4 Wound Closure Devices Distribution Share (2007-2008)
    • 13.5 Wound Closure Devices, United Kingdom, Company Share (2006-2007)
  • 14 Overview of Key Companies in United Kingdom Wound Care Management Market
    • 14.1 HARTMANN GROUP
      • 14.1.1 Company Overview
      • 14.1.2 Value Chain Analysis
        • 14.1.2.1 Manufacturing
        • 14.1.2.2 Product Development
        • 14.1.2.3 Sales and Marketing
    • 14.2 Smith & Nephew Plc
      • 14.2.1 Company Overview
      • 14.2.2 Value Chain Analysis
        • 14.2.2.1 Manufacturing
        • 14.2.2.2 Product Development
        • 14.2.2.3 Sales and Marketing
      • 14.2.3 Smith & Nephew Plc Pipeline Products
        • 14.2.3.1 Smith & Nephew Plc Pipeline Products By Equipment Type
        • 14.2.3.2 Smith & Nephew Plc Pipeline Products By Development Stage
        • 14.2.3.3 Smith & Nephew Plc Pipeline Products By Therapy Area
        • 14.2.3.4 Smith & Nephew Plc Pipeline Products By News Summary
    • 14.3 Coloplast A/S
      • 14.3.1 Company Overview
      • 14.3.2 Value Chain Analysis
        • 14.3.2.1 Manufacturing
        • 14.3.2.2 Product Development
        • 14.3.2.3 Sales and Marketing
    • 14.4 ConvaTec
      • 14.4.1 Company Overview
    • 14.5 Baxter International Inc
      • 14.5.1 Company Overview
      • 14.5.2 Value Chain Analysis
        • 14.5.2.1 Manufacturing
        • 14.5.2.2 Product Development
        • 14.5.2.3 Sales and Marketing
    • 14.6 Covidien Ltd
      • 14.6.1 Company Overview
      • 14.6.2 Value Chain Analysis
        • 14.6.2.1 Manufacturing
        • 14.6.2.2 Product Development
        • 14.6.2.3 Sales and Marketing
    • 14.7 Ethicon, Inc
      • 14.7.1 Company Overview
      • 14.7.2 Ethicon, Inc. Pipeline Products
        • 14.7.2.1 Ethicon, Inc. Pipeline Products By Equipment Type
        • 14.7.2.2 Ethicon, Inc. Pipeline Products By Development Stage
        • 14.7.2.3 Ethicon, Inc. Pipeline Products By Therapy Area
        • 14.7.2.4 Ethicon, Inc. Pipeline Products By Clinical Trials
    • 14.8 Molnlycke Health Care AB
      • 14.8.1 Company Overview
    • 14.9 Hollister Incorporated
      • 14.9.1 Company Overview
    • 14.10 BSN medical GmbH
      • 14.10.1 Company Overview
    • 14.11 Johnson & Johnson
      • 14.11.1 Company Overview
      • 14.11.2 Value Chain Analysis
        • 14.11.2.1 Manufacturing
        • 14.11.2.2 Product Development
        • 14.11.2.3 Sales and Marketing
    • 14.12 Advanced Medical Solutions Group plc
      • 14.12.1 Company Overview
      • 14.12.2 Value Chain Analysis
        • 14.12.2.1 Manufacturing
        • 14.12.2.2 Product Development
        • 14.12.2.3 Sales and Marketing
      • 14.12.3 Advanced Medical Solutions Group Plc Pipeline Products
        • 14.12.3.1 Advanced Medical Solutions Group Plc Pipeline Products By Equipment Type
        • 14.12.3.2 Advanced Medical Solutions Group Plc Pipeline Products By Development Stage
        • 14.12.3.3 Advanced Medical Solutions Group Plc Pipeline Products By Therapy Area
  • 15 Financial Deals Landscape
    • 15.1 Acquisition
      • 15.1.1 Lohmann & Rauscher Acquires Activa Healthcare
  • 16 Recent Developments
    • 16.1 Legal and Regulatory
      • 16.1.1 Jan 13, 2009: KCI Wins Temporary Injunction Order against Smith & Nephew
    • 16.2 Product News
      • 16.2.1 Oct 20, 2008: Ark Announces Launch of KerraMax Super-Absorbent Dressing
  • 17 Appendix
    • 17.1 Global Markets Direct Research Methodology
    • 17.2 Coverage
    • 17.3 Secondary Research
    • 17.4 Primary Research
    • 17.5 Models
    • 17.6 Forecasts
    • 17.7 Expert Panel Validation
    • 17.8 Currency Conversion
    • 17.9 Contact Us
    • 17.10 Disclaimer
  • 1.1 List of Tables
    • Table 1: Number of Doctor by Specialty in UK, 2003 - 2007
    • Table 2: United Kingdom Healthcare Trade Statistics, 2001-2006
    • Table 3: Medical Device Approval Fee in UK, 2006
    • Table 4: Wound Care Management Cross Country Comparison, Revenue ($ mn), 2000-2015
    • Table 5: Wound Care Management, United Kingdom, Overall Revenue ($ mn), 2000-2015
    • Table 6: Wound Care Management, United Kingdom, Cross-Category Analysis, 2000-2015
    • Table 7: Wound Care Management, United Kingdom, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 8: Wound Care Management, United Kingdom, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 9: Wound Care Management, United Kingdom, Category Volume (Units), 2000-2015
    • Table 10: Wound Care Management, United Kingdom, Category Volume (Units), Historic, 2000-2008
    • Table 11: Wound Care Management, United Kingdom, Category Volume (Units), Forecast, 2008-2015
    • Table 12: Wound Care Management, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 13: Advanced Wound Management, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 14: Advanced Wound Management, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 15: Advanced Wound Management, United Kingdom, Volume (Units) by Segment, Historic, 2000-2008
    • Table 16: Advanced Wound Management, United Kingdom, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 17: Advanced Wound Management, United Kingdom, Average Price ($), Historic, 2000-2008
    • Table 18: Advanced Wound Management, United Kingdom, Average Price ($), Forecast, 2008-2015
    • Table 19: Advanced Wound Management, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
    • Table 20: Advanced Wound Management, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 21: Compression Therapy, United Kingdom, Revenue ($ mn), Historic, 2000-2008
    • Table 22: Compression Therapy, United Kingdom, Revenue ($ mn), Forecast, 2008-2015
    • Table 23: Compression Therapy, United Kingdom, Volume (Units), Historic, 2000-2008
    • Table 24: Compression Therapy, United Kingdom, Volume (Units), Forecast, 2008-2015
    • Table 25: Compression Therapy, United Kingdom, Average Price ($), Historic, 2000-2008
    • Table 26: Compression Therapy, United Kingdom, Average Price ($), Forecast, 2008-2015
    • Table 27: Compression Therapy, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
    • Table 28: Compression Therapy, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 29: Ostomy, United Kingdom, Revenue ($ mn), Historic, 2000-2008
    • Table 30: Ostomy, United Kingdom, Revenue ($ mn), Forecast, 2008-2015
    • Table 31: Ostomy, United Kingdom, Volume (Units), Historic, 2000-2008
    • Table 32: Ostomy, United Kingdom, Volume (Units), Forecast, 2008-2015
    • Table 33: Ostomy, United Kingdom, Average Price ($), Historic, 2000-2008
    • Table 34: Ostomy, United Kingdom, Average Price ($), Forecast, 2008-2015
    • Table 35: Ostomy, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
    • Table 36: Ostomy, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 37: Traditional Wound Management, United Kingdom, Revenue ($ mn), Historic, 2000-2008
    • Table 38: Traditional Wound Management, United Kingdom, Revenue ($ mn), Forecast, 2008-2015
    • Table 39: Traditional Wound Management, United Kingdom, Volume (Units), Historic, 2000-2008
    • Table 40: Traditional Wound Management, United Kingdom, Volume (Units), Forecast, 2008-2015
    • Table 41: Traditional Wound Management, United Kingdom, Average Price ($), Historic, 2000-2008
    • Table 42: Traditional Wound Management, United Kingdom, Average Price ($), Forecast, 2008-2015
    • Table 43: Traditional Wound Management, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
    • Table 44: Traditional Wound Management, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 45: Wound Closure Devices, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 46: Wound Closure Devices, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 47: Wound Closure Devices, United Kingdom, Volume (Units) by Segment, Historic, 2000-2008
    • Table 48: Wound Closure Devices, United Kingdom, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 49: Wound Closure Devices, United Kingdom, Average Price ($), Historic, 2000-2008
    • Table 50: Wound Closure Devices, United Kingdom, Average Price ($), Forecast, 2008-2015
    • Table 51: Wound Closure Devices, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
    • Table 52: Wound Closure Devices, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 53: Smith & Nephew Plc Pipeline Products by Equipment Type
    • Table 54: Smith & Nephew Plc Pipeline Products By Development Stage
    • Table 55: Smith & Nephew Plc Pipeline Products By Therapy Area
    • Table 56: Smith & Nephew Plc Pipeline Products By News Summary
    • Table 57: Ethicon, Inc. Pipeline Products by Equipment Type
    • Table 58: Ethicon, Inc. Pipeline Products By Development Stage
    • Table 59: Ethicon, Inc. Pipeline Products By Therapy Area
    • Table 60: Ethicon, Inc. Pipeline Products By Clinical Trials
    • Table 61: Advanced Medical Solutions Group Plc Pipeline Products by Equipment Type
    • Table 62: Advanced Medical Solutions Group Plc Pipeline Products By Development Stage
    • Table 63: Advanced Medical Solutions Group Plc Pipeline Products By Therapy Area
    • Table 64: Lohmann & Rauscher Acquires Activa Healthcare
    • Table 65: USD to Local Currency, Average Exchange Rate 2008
  • 1.2 List of Figures
    • Figure 1: Total Healthcare Expenditure in UK, 2000 - 2006
    • Figure 2: Flowchart for Classification of Non-invasive Devices in UK, 2007
    • Figure 3: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 4: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 5: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 6: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 7: Flowchart for Classification of Active Devices in UK, 2007
    • Figure 8: Flowchart for Classification of Active Devices in UK, 2007
    • Figure 9: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in UK, 2007
    • Figure 10: Conformity Assessment of Class-I Medical Devices in UK, 2007
    • Figure 11: Conformity Assessment of Class-IIa Medical Devices in UK, 2007
    • Figure 12: Conformity Assessment of Class-IIb Medical Devices in UK, 2007
    • Figure 13: Conformity Assessment of Class-III Medical Devices in UK, 2007
    • Figure 14: Wound Care Management Cross Country Comparison, Revenue ($ mn), 2000-2015
    • Figure 15: Wound Care Management, United Kingdom, Overall Revenue ($ mn), 2000-2015
    • Figure 16: Wound Care Management, United Kingdom, Cross-Category Analysis, 2000-2015
    • Figure 17: Wound Care Management, United Kingdom, Overall Revenue ($ mn), Historic, 2000-2008
    • Figure 18: Wound Care Management, United Kingdom, Overall Revenue ($ mn), Forecast, 2008-2015
    • Figure 19: Wound Care Management, United Kingdom, Category Volume (Units), 2000-2015
    • Figure 20: Wound Care Management, United Kingdom, Category Volume (Units), Historic, 2000-2008
    • Figure 21: Wound Care Management, United Kingdom, Category Volume (Units), Forecast, 2008-2015
    • Figure 22: Wound Care Management, United Kingdom, Company Share (%), 2007
    • Figure 23: Advanced Wound Management, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 24: Advanced Wound Management, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 25: Advanced Wound Management, United Kingdom, Volume (Units) by Segment, Historic, 2000-2008
    • Figure 26: Advanced Wound Management, United Kingdom, Volume (Units) by Segment, Forecast, 2008-2015
    • Figure 27: Advanced Wound Management, United Kingdom, Company Share (%), 2007
    • Figure 28: Compression Therapy, United Kingdom, Revenue ($ mn), Historic, 2000-2008
    • Figure 29: Compression Therapy, United Kingdom, Revenue ($ mn), Forecast, 2008-2015
    • Figure 30: Compression Therapy, United Kingdom, Volume (Units), Historic, 2000-2008
    • Figure 31: Compression Therapy, United Kingdom, Volume (Units), Forecast, 2008-2015
    • Figure 32: Compression Therapy, United Kingdom, Company Share (%), 2007
    • Figure 33: Ostomy, United Kingdom, Revenue ($ mn), Historic, 2000-2008
    • Figure 34: Ostomy, United Kingdom, Revenue ($ mn), Forecast, 2008-2015
    • Figure 35: Ostomy, United Kingdom, Volume (Units), Historic, 2000-2008
    • Figure 36: Ostomy, United Kingdom, Volume (Units), Forecast, 2008-2015
    • Figure 37: Ostomy, United Kingdom, Company Share (%), 2007
    • Figure 38: Traditional Wound Management, United Kingdom, Revenue ($ mn), Historic, 2000-2008
    • Figure 39: Traditional Wound Management, United Kingdom, Revenue ($ mn), Forecast, 2008-2015
    • Figure 40: Traditional Wound Management, United Kingdom, Volume (Units), Historic, 2000-2008
    • Figure 41: Traditional Wound Management, United Kingdom, Volume (Units), Forecast, 2008-2015
    • Figure 42: Traditional Wound Management, United Kingdom, Company Share (%), 2007
    • Figure 43: Wound Closure Devices, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 44: Wound Closure Devices, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 45: Wound Closure Devices, United Kingdom, Volume (Units) by Segment, Historic, 2000-2008
    • Figure 46: Wound Closure Devices, United Kingdom, Volume (Units) by Segment, Forecast, 2008-2015
    • Figure 47: Wound Closure Devices, United Kingdom, Company Share (%), 2007
    • Figure 48: Hartmann Group Value Chain Analysis
    • Figure 49: Smith & Nephew Plc Value Chain Analysis
    • Figure 50: Coloplast A/S Value Chain Analysis
    • Figure 51: Baxter International Inc. Value Chain Analysis
    • Figure 52: Covidien Ltd./Tyco Healthcare Value Chain Analysis
    • Figure 53: Johnson & Johnson Value Chain Analysis
    • Figure 54: Advanced Medical Solutions Group Plc Value Chain Analysis
    • Figure 55: Global Markets Direct Methodology
Delivery Details

PDF:Delivered by email usually within 12 to 24 UK business hours.

Product features / use
Scope Expert Insight/Opinion yes
Profiles In-depth Company Insight yes
Features Primary Research Data yes

Industry Events

2nd International Conference on Drug Discovery and Therapy

01 Feb 10 to 04 Feb 10
Dubai, United Arab Emirates
view summary >>

Oncology Market & Patient Access

14 Dec 09 to 16 Dec 09
Prague, Czech Republic
view summary >>